These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1778862)

  • 1. In-vitro susceptibility of Rhodococcus equi to 27 antibiotics.
    Decré D; Buré A; Pangon B; Phillippon A; Bergogne-Bérézin E
    J Antimicrob Chemother; 1991 Aug; 28(2):311-3. PubMed ID: 1778862
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi.
    Berghaus LJ; Giguère S; Guldbech K; Warner E; Ugorji U; Berghaus RD
    J Clin Microbiol; 2015 Jan; 53(1):314-8. PubMed ID: 25378571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonization of antimicrobial susceptibility testing by broth microdilution for Rhodococcus equi of animal origin.
    Riesenberg A; Feßler AT; Frömke C; Kadlec K; Klarmann D; Kreienbrock L; Werckenthin C; Schwarz S
    J Antimicrob Chemother; 2013 Sep; 68(9):2173-5. PubMed ID: 23603553
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial activity of tulathromycin and 14 other antimicrobials against virulent Rhodococcus equi in vitro.
    Carlson KL; Kuskie KR; Chaffin KM; Libal MC; Giguère S; Lawhon SD; Cohen ND
    Vet Ther; 2010; 11(2):E1-9. PubMed ID: 20957614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals.
    Bowersock TL; Salmon SA; Portis ES; Prescott JF; Robison DA; Ford CW; Watts JL
    Antimicrob Agents Chemother; 2000 May; 44(5):1367-9. PubMed ID: 10770781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro antimicrobial susceptibility of Rhodococcus equi.
    Nordmann P; Ronco E
    J Antimicrob Chemother; 1992 Apr; 29(4):383-93. PubMed ID: 1607327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
    Boyen F; Pasmans F; Haesebrouck F
    Vet Rec; 2011 Jan; 168(4):101a. PubMed ID: 21257598
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Del Prete MS; Licci A; D'Amato G; Lukasiak J; Scalise G
    J Antimicrob Chemother; 2005 Aug; 56(2):410-2. PubMed ID: 15983026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
    Giacometti A; Cirioni O; Ancarani F; Del Prete MS; Fortuna M; Scalise G
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2093-6. PubMed ID: 10428947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Resistance in
    Giguère S; Berghaus LJ; Willingham-Lane JM
    Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility testing of Rhodococcus equi: An interlaboratory test.
    Riesenberg A; Kaspar H; Feßler AT; Werckenthin C; Schwarz S
    Vet Microbiol; 2016 Oct; 194():30-35. PubMed ID: 26711505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Rhodococcus equi Infections Based on Immune Status and Antibiotic Susceptibility of Clinical Isolates in a Case Series of 12 Patients and Cases in the Literature.
    Gundelly P; Suzuki Y; Ribes JA; Thornton A
    Biomed Res Int; 2016; 2016():2737295. PubMed ID: 27631004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance in Rhodococcus equi.
    Cisek AA; Rzewuska M; Witkowski L; Binek M
    Acta Biochim Pol; 2014; 61(4):633-8. PubMed ID: 25371917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linalool production from the leaves of Bursera aloexylon and its antimicrobial activity.
    Queiroga CL; Duarte MC; Ribeiro BB; de Magalhães PM
    Fitoterapia; 2007 Jun; 78(4):327-8. PubMed ID: 17482377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
    Berghaus LJ; Giguère S; Guldbech K
    Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice.
    Burton AJ; Giguère S; Berghaus LJ; Hondalus MK
    Antimicrob Agents Chemother; 2015; 59(6):3633-6. PubMed ID: 25824218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
    Giguère S; Lee E; Williams E; Cohen ND; Chaffin MK; Halbert N; Martens RJ; Franklin RP; Clark CC; Slovis NM
    J Am Vet Med Assoc; 2010 Jul; 237(1):74-81. PubMed ID: 20590498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi.
    Coleman M; Kuskie K; Liu M; Chaffin K; Libal M; Giguère S; Bernstein L; Cohen N
    Vet Microbiol; 2010 Nov; 146(1-2):175-8. PubMed ID: 20554401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhodococcus equi: first case in a heart transplant recipient.
    Segovia J; Pulpón LA; Crespo MG; Daza R; Rodríguez JC; Rubio A; Serrano S; Carreño MC; Varela A; Arangüena R
    J Heart Lung Transplant; 1994; 13(2):332-5. PubMed ID: 8031817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of Rhodococcus equi isolates from horse and man].
    Fuhrmann C; Lämmler C
    Berl Munch Tierarztl Wochenschr; 1997 Feb; 110(2):54-9. PubMed ID: 9139629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.